BridgeBio Pharma (BBIO) EBT Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,688.00 |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 4,249.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,249.00 |
| Dec 31, 2025 | 439,997.00 |
| Sep 30, 2025 | 585,773.00 |
| Jun 30, 2025 | 332,020.00 |
| Mar 31, 2025 | -9,138.00 |
| Dec 31, 2024 | 648,266.00 |
| Sep 30, 2024 | -175,398.00 |
| Jun 30, 2024 | 639,844.00 |
| Mar 31, 2024 | 777,471.00 |
| Dec 31, 2023 | -324,798.00 |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | -974,776.00 |
| Mar 31, 2023 | 365,399.00 |
| Dec 31, 2022 | -595,530.00 |
| Sep 30, 2022 | -3.65 Mn |
| Jun 30, 2022 | 109,460.00 |
| Mar 31, 2022 | 2.68 Mn |
| Dec 31, 2021 | 11.13 Mn |
| Sep 30, 2021 | -523,833.00 |
| Sep 30, 2020 | -139,987.00 |